Cause of Premature Deaths Among Living-Donor Kidney Transplants: An Outcome Nobody Wants

Background: Kidney transplant offers survival advantage to end stage renal disease patients compared to those remaining on dialysis. Living donor kidney transplant (LDKT) is considered superior to deceased donor kidney transplant offering additional graft and patient survival benefits. Here, we investigate the cause of early deaths within 5 years of a LDKT and the pertinent characteristics of this cohort. Methods: This is a retrospective study of LDKT at the University of Pennsylvania between 1/1/2015 and 11/30/2023. Premature death was defined as deaths within 5 years of LDKT (n=15). Extensive chart reviews were done and cause of deaths were classified. Presence of pre-existing risk factors, use of immunosuppression, and frequency of post-transplant admissions were recorded. Results: Infection was the most common cause of premature death (46.7%, N=7), accounting for deaths in nearly all 5 years post transplant. This was followed by cardiovascular complications (20%, N=3), which occurred with higher frequency within the first 2 years post-transplant. Around 86.7% (N=13) patients died with a functioning graft. There were 10 patients who were hospitalized 5 or more times post transplant before their death. Conclusion: Deaths within the first 5 years of LDKT were most commonly deaths with a functioning graft. Infectious and cardiovascular causes are the leading causes of deaths. Judicious use of immunosuppression and aggressive cardiovascular care is necessary to avoid these premature deaths.1Ethnicity W=White, Non-Hispanic B=Black, Non-Hispanic

Authors

Institutions

Publication Details

Journal
Journal of the American Society of Nephrology
Published
2025-10-01
DOI
https://doi.org/10.1681/asn.2025k0kjyhbh
Primary Topic
Renal Transplantation Outcomes and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cause of Premature Deaths Among Living-Donor Kidney Transplants: An Outcome Nobody Wants

Divyash V. Shah, Srijan Tandukar, Pranav S. Kancherla, Sneha Chandrashekar et al.
Journal of the American Society of Nephrology
Renal Transplantation Outcomes and Treatments
article

Cause of Premature Deaths Among Living-Donor Kidney Transplants: An Outcome Nobody Wants

Divyash V. Shah, Srijan Tandukar, Pranav S. Kancherla, Sneha Chandrashekar, Misha R Bankulla
article en

Abstract

Background: Kidney transplant offers survival advantage to end stage renal disease patients compared to those remaining on dialysis. Living donor kidney transplant (LDKT) is considered superior to deceased donor kidney transplant offering additional graft and patient survival benefits. Here, we investigate the cause of early deaths within 5 years of a LDKT and the pertinent characteristics of this cohort. Methods: This is a retrospective study of LDKT at the University of Pennsylvania between 1/1/2015 and 11/30/2023. Premature death was defined as deaths within 5 years of LDKT (n=15). Extensive chart reviews were done and cause of deaths were classified. Presence of pre-existing risk factors, use of immunosuppression, and frequency of post-transplant admissions were recorded. Results: Infection was the most common cause of premature death (46.7%, N=7), accounting for deaths in nearly all 5 years post transplant. This was followed by cardiovascular complications (20%, N=3), which occurred with higher frequency within the first 2 years post-transplant. Around 86.7% (N=13) patients died with a functioning graft. There were 10 patients who were hospitalized 5 or more times post transplant before their death. Conclusion: Deaths within the first 5 years of LDKT were most commonly deaths with a functioning graft. Infectious and cardiovascular causes are the leading causes of deaths. Judicious use of immunosuppression and aggressive cardiovascular care is necessary to avoid these premature deaths.1Ethnicity W=White, Non-Hispanic B=Black, Non-Hispanic

Journal of the American Society of NephrologyVol. 36(10S)
University of Pennsylvania (US)
Openalex Percentile: Top 42%
Renal Transplantation Outcomes and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.